Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Hoechst discovers modulators of leukocyte adhesion and migration

Aug. 12, 1998

COX-2 inhibitors selective for the human enzyme discovered at Nycomed Innovations

Aug. 11, 1998

Bayer discovers new MMP inhibitors for arthritic diseases

Aug. 11, 1998

FDA committee recommends approval of Arava for the treatment of rheumatoid arthritis

Aug. 11, 1998

Hoechst describes new compounds for rheumatoid arthritis and allergy

Aug. 11, 1998

Cypress Bioscience files PMA for Prosorba Column

July 28, 1998

Zeneca presents peptides for modifying autoimmune responses as in RA

July 27, 1998

Alexion's C5 inhibitor enters clinic for second autoimmune disorder

July 24, 1998

Dipeptidyl peptidase IV inhibitors developed at Tanabe

July 24, 1998

Antiinflammatory/immunomodulating peptide available for licensing from BTG

July 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...